AAAAAA

   
Results: 1-16 |
Results: 16
Prevalence and distribution of HHV-8 in different subpopulations, with andwithout HIV infection, in Spain
Authors: Gambus, G Bourboulia, D Esteve, A Lahoz, R Rodriguez, C Bolao, F Sirera, G Muga, R del Romero, J Boshoff, C Whitby, D Casabona, J
Citation: G. Gambus et al., Prevalence and distribution of HHV-8 in different subpopulations, with andwithout HIV infection, in Spain, AIDS, 15(9), 2001, pp. 1167-1174
Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy
Authors: Tuldra, A Fumaz, CR Ferrer, MJ Bayes, R Arno, A Balague, M Bonjoch, A Jou, A Negredo, E Paredes, R Ruiz, L Romeu, J Sirera, G Tural, C Burger, D Clotet, B
Citation: A. Tuldra et al., Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy, J ACQ IMM D, 25(3), 2000, pp. 221-228
Mortality of HIV-positive and HIV-negative heroin abusers as a function ofduration of injecting drug use
Authors: Muga, R Roca, J Egea, JM Tor, J Sirera, G Rey-Joly, C Munoz, A
Citation: R. Muga et al., Mortality of HIV-positive and HIV-negative heroin abusers as a function ofduration of injecting drug use, J ACQ IMM D, 23(4), 2000, pp. 332-338
Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIV
Authors: Puig-Basagoiti, F Cabana, M Guilera, M Gimenez-Barcons, M Sirera, G Tural, C Clotet, B Sanchez-Tapias, JM Rodes, J Saiz, JC Martinez, MA
Citation: F. Puig-basagoiti et al., Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIV, J ACQ IMM D, 23(1), 2000, pp. 89-94
Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients
Authors: Podzamczer, D Miro, JM Ferrer, E Gatell, JM Ramon, JM Ribera, E Sirera, G Cruceta, A Knobel, H Domingo, P Polo, R Leyes, M Cosin, J Farinas, MC Arrizabalaga, J Martinez-Lacasa, J Gudiol, F
Citation: D. Podzamczer et al., Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients, EUR J CL M, 19(2), 2000, pp. 89-95
Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression
Authors: Ruiz, L Martinez-Picado, J Romeu, J Paredes, R Zayat, MK Marfil, S Negredo, E Sirera, G Tural, C Clotet, B
Citation: L. Ruiz et al., Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression, AIDS, 14(4), 2000, pp. 397-403
Diffuse infiltrative CD8 lymphocytosis syndrome in a patient with HIV-1 infection
Authors: Sancho, JM Ribera, JM Vaquero, M Sirera, G
Citation: Jm. Sancho et al., Diffuse infiltrative CD8 lymphocytosis syndrome in a patient with HIV-1 infection, MED CLIN, 115(10), 2000, pp. 399-399
Hodgkin's disease in patients infected by the human immunodeficiency virus. Study of fifteen cases
Authors: Navarro, JT Ribera, JM Grau, J Frias, C Vaquero, M Sirera, G Batile, M Milla, F Feliu, E
Citation: Jt. Navarro et al., Hodgkin's disease in patients infected by the human immunodeficiency virus. Study of fifteen cases, MED CLIN, 114(1), 2000, pp. 19-21
High-dose saquinavir plus ritonavir: Long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response
Authors: Paredes, R Puig, T Arno, A Negredo, E Balague, M Bonjoch, A Jou, A Tuldra, A Tural, C Sirera, G Veny, A Romeu, J Ruiz, L Clotet, B
Citation: R. Paredes et al., High-dose saquinavir plus ritonavir: Long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response, J ACQ IMM D, 22(2), 1999, pp. 132-138
Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up
Authors: Negredo, E Paredes, R Bonjoch, A Tuldra, A Fumaz, CR Gel, S Garces, B Johnston, S Arno, A Balague, M Jou, A Tural, C Sirera, G Romeu, J Cruz, L Francia, E Domingo, P Arrizabalaga, J Ruiz, I Arribas, JR Ruiz, L Clotet, B
Citation: E. Negredo et al., Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up, ANTIVIR TH, 4, 1999, pp. 23-28
Absence of Fas (CD95) and FasL (CD95L) immunohistochemical expression suggests Fas/FasL-mediated apoptotic signal is not relevant in cutaneous Kaposi's sarcoma lesions
Authors: Fernandez-Figueras, MT Armengol, P Puig, L Molinero, JL Esquius, M Sirera, G Ariza, A
Citation: Mt. Fernandez-figueras et al., Absence of Fas (CD95) and FasL (CD95L) immunohistochemical expression suggests Fas/FasL-mediated apoptotic signal is not relevant in cutaneous Kaposi's sarcoma lesions, J CUT PATH, 26(9), 1999, pp. 417-423
Short-term risk for AIDS-indicator diseases predicted by plasma HIV-1 RNA and CD4+lymphocytes
Authors: Romeu, J Balague, M Ruiz, L Marfil, S Gatell, JM Puig, T Arno, A Tural, C Sirera, G Clotet, B
Citation: J. Romeu et al., Short-term risk for AIDS-indicator diseases predicted by plasma HIV-1 RNA and CD4+lymphocytes, SC J IN DIS, 31(1), 1999, pp. 37-42
Is Leishmania infantum zymodeme MON-253 involved in an outbreak among intravenous drug users?
Authors: Chicharro, C Sirera, G Ares, M Sans, A Videla, S Alvar, J
Citation: C. Chicharro et al., Is Leishmania infantum zymodeme MON-253 involved in an outbreak among intravenous drug users?, T RS TROP M, 93(4), 1999, pp. 385-386
Primary gastrointestinal lymphomas in HIV-patients: report of 15 cases from a series of 76 patients with HIV related non-Hodgkin's lymphoma
Authors: Hernandez, JA Navarro, JT Ribera, JM Sancho, JM Vaquero, M Sirera, G Batlle, M Milla, F Feliu, E
Citation: Ja. Hernandez et al., Primary gastrointestinal lymphomas in HIV-patients: report of 15 cases from a series of 76 patients with HIV related non-Hodgkin's lymphoma, MED CLIN, 112(6), 1999, pp. 222-224
Morrtality in a cohort of intravenous drug users before HAART therapy
Authors: Muga, R Egea, JM Navio, M Sirera, G Vall, M Tor, J
Citation: R. Muga et al., Morrtality in a cohort of intravenous drug users before HAART therapy, MED CLIN, 112(19), 1999, pp. 721-725
Severe interaction between ritonavir and acenocumarol
Authors: Llibre, JM Romeu, J Lopez, E Sirera, G
Citation: Jm. Llibre et al., Severe interaction between ritonavir and acenocumarol, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 183-186
Risultati: 1-16 |